Exploring the Potential Medicinal Benefits of Ganoderma lucidum: From Metabolic Disorders to Coronavirus Infections
المؤلف | Ekiz, Elif |
المؤلف | Oz, Emel |
المؤلف | Abd El-Aty, A. M. |
المؤلف | Proestos, Charalampos |
المؤلف | Brennan, Charles |
المؤلف | Zeng, Maomao |
المؤلف | Tomasevic, Igor |
المؤلف | Elobeid, Tahra |
المؤلف | Çadırcı, Kenan |
المؤلف | Bayrak, Muharrem |
المؤلف | Oz, Fatih |
تاريخ الإتاحة | 2023-05-14T11:20:33Z |
تاريخ النشر | 2023-04-01 |
اسم المنشور | Foods |
المعرّف | http://dx.doi.org/10.3390/foods12071512 |
الاقتباس | Ekiz, E., Oz, E., Abd El-Aty, A. M., Proestos, C., Brennan, C., Zeng, M., ... & Oz, F. (2023). Exploring the Potential Medicinal Benefits of Ganoderma lucidum: From Metabolic Disorders to Coronavirus Infections. Foods, 12(7), 1512. |
الملخص | Ganoderma lucidum is a medicinal mushroom that has been traditionally used in Chinese medicine for centuries. It has been found to have a wide range of medicinal properties, including antioxidant, anti-inflammatory, and immune-boosting effects. Recent research has focused on the potential benefits of G. lucidum in treating metabolic disorders such as diabetes and obesity, as well as its possible role in preventing and treating infections caused by the coronavirus. Triterpenoids are a major group of bioactive compounds found in G. lucidum, and they have a range of biological activities, including anti-inflammatory and antioxidant properties. These compounds have been found to improve insulin sensitivity and lower blood sugar levels in animal models of diabetes. Additionally, G. lucidum polysaccharides have been found to reduce bodyweight and improve glucose metabolism in animal models of obesity. These polysaccharides can also help to increase the activity of certain white blood cells, which play a critical role in the body’s immune response. For coronavirus, some in vitro studies have shown that G. lucidum polysaccharides and triterpenoids have the potential to inhibit coronavirus infection; however, these results have not been validated through clinical trials. Therefore, it would be premature to draw any definitive conclusions about the effectiveness of G. lucidum in preventing or treating coronavirus infections in humans. |
اللغة | en |
الناشر | MDPI |
الموضوع | anticancer antidiabetic antioxidant bioactive compounds cardiovascular diseases COVID-19 Ganoderma lucidum |
النوع | Article |
رقم العدد | 7 |
رقم المجلد | 12 |
الملفات في هذه التسجيلة
الملفات | الحجم | الصيغة | العرض |
---|---|---|---|
لا توجد ملفات لها صلة بهذه التسجيلة. |
هذه التسجيلة تظهر في المجموعات التالية
-
أبحاث فيروس كورونا المستجد (كوفيد-19) [811 items ]
-
التغذية البشرية [373 items ]